Mirum Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced that on November 8, 2024, its Compensation Committee granted inducement awards to seven new employees under the company’s 2020 Inducement Plan. These awards consist of non-qualified stock options to purchase 56,100 shares of common…

Read MoreMirum Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

Cencora Expands Specialty Leadership with Acquisition of Retina Consultants of America

Cencora, Inc. (NYSE: COR), a global leader in pharmaceutical solutions, today announced it has entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services organization (MSO) for retina specialists, from Webster Equity Partners. The…

Read MoreCencora Expands Specialty Leadership with Acquisition of Retina Consultants of America

Castle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting

Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests at the 61st Annual Meeting of the American Society of…

Read MoreCastle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting

Palleon Pharmaceuticals Presents GLIMMER-01 Trial Results of E-602 and Cemiplimab at SITC Annual Meeting

Palleon Pharmaceuticals, a clinical-stage company leading innovation in glyco-immunology for autoimmune diseases and cancer, today announced results from the Phase 1/2 GLIMMER-01 trial of E-602. This first-in-class human sialidase enzyme therapeutic was tested in combination with the PD-1 inhibitor cemiplimab…

Read MorePalleon Pharmaceuticals Presents GLIMMER-01 Trial Results of E-602 and Cemiplimab at SITC Annual Meeting

Square Knot Health Enhances Kidney Transplant Access, Reports at ASN Kidney Week

Square Knot Health, a leader in technology-driven kidney transplant care, has achieved outstanding results with its innovative care model designed to help patients navigate the complexities of kidney transplantation. The company’s unique approach streamlines the transplant process, improving access and…

Read MoreSquare Knot Health Enhances Kidney Transplant Access, Reports at ASN Kidney Week